Effect of the Xanthine Oxidase Inhibitor Febuxostat on the Cardio-Ankle Vascular Index in Asymptomatic Patients with Hyperuricemia and Liver Dysfunction: A Sub-Analysis of the PRIZE Study
Two-year treatment with febuxostat demonstrated a beneficial effect on CAVI in patients with hyperuricemia and liver dysfunction.
Authors
- Yusuke Kawachi (ORCID: https://orcid.org/0009-0006-8676-9049)
- Hitoshi Nishizawa (ORCID: https://orcid.org/0000-0002-7845-9693)
- Atsushi Tanaka (ORCID: https://orcid.org/0000-0003-3352-7661)
- Hisako Yoshida (ORCID: https://orcid.org/0000-0002-5999-5773)
- Iichiro Shimomura (ORCID: https://orcid.org/0000-0002-0851-9603)
- Shinichi Niwano (ORCID: https://orcid.org/0000-0002-0702-0800)
- Koichi Node (ORCID: https://orcid.org/0000-0002-2534-0939)
- Yuya Fujishima (ORCID: https://orcid.org/0000-0003-0028-1757)
- Makoto Suzuki (ORCID: https://orcid.org/0009-0007-4761-4877)
Institutions
- Saga University (JP)
- Yokohama Minami Kyosai Hospital (JP)
- Osaka Metropolitan University (JP)
- Kitasato University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Atherosclerosis and Thrombosis
- Published
- 2024-10-02
- DOI
- https://doi.org/10.5551/jat.65087
- Citations
- 4
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Suzuken Memorial Foundation
- Taiju Life Social Welfare Foundation
- Teijin Pharma